Uncertain benefit, certain harm: the anticoagulation paradox in hemodialysis—re-evaluation of stroke prevention and bleeding risk in end-stage kidney disease
Tae-Wan Chung
Korean J Intern Med. 2026;41(1):3-5. Published online 2026 Jan 1 DOI: https://doi.org/10.3904/kjim.2025.406
Citations to this article as recorded by 
Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, nonsteroidal MRA, and GLP-1 RA, and presence of high competing mortality
Carmine Zoccali, Csaba Kovesdy, Francesca Mallamaci, Wolfgang C Winkelmayer, Emelia J Benjamin
Nephrology Dialysis Transplantation.2026;[Epub] CrossRef